Trans Genic Current Assets

Trans Genic (2342.T) currently reports a current assets of $6.8B as of June 2026. That compares with $6.9B in the prior-year period — down 1.1% year over year. Use the charts on this page to explore Trans Genic's current assets history and peer comparisons.

Trans Genic's current assets decreased from $6.9B to $6.8B — a 1.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Trans Genic reported $6.8B in current assets as of June 2026. That compares with $6.9B in the prior-year period — down 1.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $6.8B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Trans Genic, and consider following 2342.T for alerts when major investors trade the stock.

Trans Genic is classified in the Healthcare sector. On current assets, it currently shows $6.8B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 2342.T with unrelated industries.